Pharma

Related Articles

Mesenchymal Stem Cells for Therapeutic Purposes
Transplantation, 10/07/09    Relevance Score: 64%

Allos Therapeutics to Present at Upcoming Conferences in November
Allos Therapeutics, 11/11/09    Relevance Score: 45%

ImmunoGen, Inc. Announces Presentations at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
ImmunoGen, Inc., 11/11/09    Relevance Score: 43%

Allos Therapeutics to Report Third Quarter 2009 Results on November 2009
Allos Therapeutics, 10/27/09    Relevance Score: 43%

Agonists and allosteric modulators of the Calcium Sensing Receptor and their therapeutic applications
Molecular Pharmacology, 10/02/09    Relevance Score: 43%

Today in Drug Trials...keeping you current

Bayer Starts Phase III Trial with Florbetaben
BayNews International, 12/01/09

Bioequivalence of two film-coated tablets of imatinib mesylate 400 mg: A randomized, open-label, single-dose, fasting, two-period, two-sequence crossover comparison in healthy male South American volunteers
Clinical Therapeutics, 12/01/09

Directly observed antiretroviral therapy: a systematic review and meta-analysis of randomised clinical trials
The Lancet - Early Online Publication, 12/01/09

Today in Research & Development...keeping you current

Allos Therapeutics Announces Issuance of U.S. Patent for FOLOTYN
Allos Therapeutics, 12/01/09

New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents
Cell Therapeutics, 12/01/09

Bayer Starts Phase III Trial with Florbetaben
BayNews International, 12/01/09